Poland· PL-100065657
Tarcefandol
A cefamandole product containing cefamandolum, registered in Poland by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cefamandole is registered in 3 of 19 countries.
Countries holding a registration under ATC J01DC03 (cefamandole), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Cefamandole · ATC J01DC03
3 / 19 countries
- Finlandprice
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Cefamandolum
- Manufacturer
- Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- Country
- Poland (PL)
- ATC code
- J01DC03
- ATC class
- Cefamandole
- Defined daily dose
- 6 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990361212
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for cefamandole.
Graded by severity as the source publishes them — 25 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefamandole · interactions on record
25 records
- 25 moderate
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefamandole in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff3f067e-5f1f-44b7-997c-1418b4c5330c GET /v1/drugs/ff3f067e-5f1f-44b7-997c-1418b4c5330c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "1 g",
"packaging": "05909990361212 ¦ Rp ¦ 9875\n1 fiol. 1 g proszku",
"substance": "Cefamandolum 1 g",
"common_name": "Cefamandolum",
"pl_product_id": "100065657",
"pozwolenie_nr": "03612",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about cefamandole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.